deltatrials
Completed OBSERVATIONAL NCT00478894

Multicenter Orthopaedic Outcomes Network (MOON) ACL Reconstruction (ACLR): Onsite Follow-up (MOON-Onsite)

Multicenter Orthopaedic Outcomes Network (MOON) Anterior Cruciate Ligament (ACL) Reconstruction (ACLR): Onsite Follow-up

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Updated 17 times since 2017 Last updated: Jan 25, 2026 Started: Aug 31, 2007 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Osteoarthritis and Rupture of Anterior Cruciate Ligament, this trial is completed. The trial is conducted by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and has accumulated 17 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Dec 2017 · 11 months · monthly snapshot~Dec 2017 – ~Apr 2018 · 4 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshot~Apr 2019 – ~May 2020 · 13 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Oct 2021 · 4 months · monthly snapshot~Oct 2021 – ~Feb 2022 · 4 months · monthly snapshot~Feb 2022 – ~Apr 2023 · 14 months · monthly snapshot~Apr 2023 – ~Mar 2024 · 11 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshot~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshot~Feb 2026 – present · 7 months · monthly snapshot

Change History

17 versions recorded
  1. Feb 2026 — Present [monthly]

    Completed

    Status: Active Not RecruitingCompleted

  2. Sep 2025 — Feb 2026 [monthly]

    Active Not Recruiting

  3. Feb 2025 — Sep 2025 [monthly]

    Active Not Recruiting

  4. Sep 2024 — Feb 2025 [monthly]

    Active Not Recruiting

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

Show 12 earlier versions
  1. Mar 2024 — Jul 2024 [monthly]

    Active Not Recruiting

  2. Apr 2023 — Mar 2024 [monthly]

    Active Not Recruiting

  3. Feb 2022 — Apr 2023 [monthly]

    Active Not Recruiting

  4. Oct 2021 — Feb 2022 [monthly]

    Active Not Recruiting

  5. Jun 2021 — Oct 2021 [monthly]

    Active Not Recruiting

    Status: Enrolling By InvitationActive Not Recruiting

  6. Jan 2021 — Jun 2021 [monthly]

    Enrolling By Invitation

  7. May 2020 — Jan 2021 [monthly]

    Enrolling By Invitation

  8. Apr 2019 — May 2020 [monthly]

    Enrolling By Invitation

  9. Jun 2018 — Apr 2019 [monthly]

    Enrolling By Invitation

  10. Apr 2018 — Jun 2018 [monthly]

    Enrolling By Invitation

    Phase: NANone

  11. Dec 2017 — Apr 2018 [monthly]

    Enrolling By Invitation NA

  12. Jan 2017 — Dec 2017 [monthly]

    Enrolling By Invitation NA

    First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • National Institutes of Health (NIH)
  • Vanderbilt University
Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .